Pnc Financial Services Group, Inc. Collegium Pharmaceutical, Inc Transaction History
Pnc Financial Services Group, Inc.
- $148 Billion
- Q4 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 575 shares of COLL stock, worth $17,721. This represents 0.0% of its overall portfolio holdings.
Number of Shares
575
Previous 912
36.95%
Holding current value
$17,721
Previous $35,000
54.29%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding COLL
# of Institutions
252Shares Held
37.5MCall Options Held
100KPut Options Held
10K-
Black Rock Inc. New York, NY5.79MShares$179 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$81.2 Million1.79% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.35MShares$72.3 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.14MShares$66 Million0.15% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.66MShares$51 Million0.1% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.05B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...